Mangorx addresses $49.3 billion global glp-1 market with launch of oral semaglutide for advanced weight loss treatment

Mangorx aims to capitalize on growing demand for glp-1 treatments to drive revenue growth and expand market share in the weight loss category

MGRX Ratings Summary

MGRX Quant Ranking